PCV69 - Cost-Effectiveness Analysis of Apixaban Versus Rivaroxaban for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain

Saved in:
Bibliographic Details
Published inValue in health Vol. 16; no. 7; p. A523
Main Authors Canal Fontcuberta, C., Escolar Albaladejo, G., Betegón Nicolás, L., de Salas-Cansado, M., Rubio-Rodríguez, D., Rubio-Terrés, C.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.11.2013
Online AccessGet full text

Cover

Loading…
More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2013.08.1268